Tyrosine phosphorylation of caveolin-2 at residue 27: Differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27)

Biochemistry

Volumn 43, Issue 43, 2004, Pages 13694-13706

  Xiao, Bo Wang ^a   Lee, Hyangkyu ^a,b   Capozza, Franco ^a   Marmon, Shana ^a   Sotgia, Federica ^a   Brooks, James W ^c   Campos Gonzalez, Roberto ^c   Lisanti, Michael P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BD Biosciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BIOCHEMISTRY; CELLS; CONCENTRATION (PROCESS); FLUORESCENCE; OLIGOMERS;

IMMUNOFLUORESCENCE; MUTATION; OLIGOMERIZATION; PHOSPHORYLATION;

PROTEINS;

ALANINE; CAVEOLIN 2; EPIDERMAL GROWTH FACTOR; LIPID; TYROSINE;

ANIMAL CELL; ARTICLE; CELL COMMUNICATION; CELL STRAIN 3T3; CELL STRAIN COS7; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MUTATION; NONHUMAN; OLIGOMERIZATION; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BINDING SITES, ANTIBODY; CAVEOLIN 2; CAVEOLINS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; COS CELLS; EPIDERMAL GROWTH FACTOR; HUMANS; MEMBRANE MICRODOMAINS; MICE; MOLECULAR WEIGHT; NIH 3T3 CELLS; ONCOGENE PROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RAS GTPASE-ACTIVATING PROTEINS; SRC HOMOLOGY DOMAINS; SUBCELLULAR FRACTIONS; TRANSFECTION;

ANIMALIA;

EID: 7244258688     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049295+     Document Type: Article

References (50)

1. Palade, G. E. (1953) Fine Structure of Blood Capillaries, J. Appl. Phys. 24, 1424-1436.
2. Yamada, E. (1955) The fine structure of the gall bladder epithelium of the mouse, J. Biophys. Biochem. Cytol. 1, 445-458.
3. Couet, J., Li, S., Okamoto, T., Scherer, P. S., and Lisanti, M. P. (1997) Molecular and cellular biology of caveolae: Paradoxes and Plasticities, Trends Cardiovasc. Med. 7, 103-110.
4. Fielding, P. E., and Fielding, C. J. (1995) Plasma membrane caveolae mediate the efflux of cellular free cholesterol, Biochemistry 34, 14288-14292.
5. Lisanti, M. P., Scherer, P., Tang, Z.-L., and Sargiacomo, M. (1994) Caveolae, caveolin and caveolin-rich membrane domains: A signalling hypothesis, Trends Cell Biol. 4, 231-235.
6. Anderson, R. G., Kamen, B. A., Rothberg, K. G., and Lacey, S. W. (1992) Potocytosis: sequestration and transport of small molecules by caveolae, Science 255 (5043), 410-411.
7. Smart, E. J., Ying, Y.-S., Donzell, W. C., and Anderson, R. G. W. (1996) A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane, J. Biol. Chem. 271, 29427-29435.
8. Smart, E. J., Graf, G. A., McNiven, M. A., Sessa, W. C., Engelman, J. A., Scherer, P. E., Okamoto, T., and Lisanti, M. P. (1999) Caveolins, liquid-ordered domains, and signal transduction, Mol. Cell. Biol. 19 (11), 7289-7304.
9. Glenney, J. R., Jr., and Soppet, D. (1992) Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts, Proc. Natl. Acad. Sci. U.S.A. 89 (21), 10517-10521.
10. Engelman, J. A., Zhang, X. L., Galbiati, F., Volonte, D., Sotgia, F., Pestell, R. G., Minetti, C., Scherer, P. E., Okamoto, T., and Lisanti, M. P. (1998) Molecular Genetics of the Caveolin Gene Family: Implications for Human Cancers, Diabetes, Alzheimer's Disease, and Muscular Dystrophy, Am. J. Hum. Genet. 63, 1578-1587.
11. Scherer, P. E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H. F., and Lisanti, M. P. (1996) Identification, sequence and expression of caveolin-2 defines a caveolin gene family, Proc. Natl. Acad. Sci. U.S.A. 93, 131-135.
12. Tang, Z.-L., Scherer, P. E., Okamoto, T., Song, K., Chu, C., Kohtz, D. S., Nishimoto, I., Lodish, H. F., and Lisanti, M. P. (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle, J. Biol. Chem. 271, 2255-2261.
13. Song, K. S., Scherer, P. E., Tang, Z.-L., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D. S., and Lisanti, M. P. (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and cofractionates with dystrophin and dystrophin-associated glycoproteins, J. Biol. Chem. 271, 15160-15165.
14. Way, M., and Parton, R. (1995) M-caveolin, a muscle-specific caveolin-related protein, FEBS Lett. 376, 108-112.
15. Li, S., Song, K. S., Koh, S. S., Kikuchi, A., and Lisanti, M. P. (1996) Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolar biogenesis, J. Biol. Chem. 271, 28647-28654.
16. Razani, B., Woodman, S. E., and Lisanti, M. P. (2002) Caveolae: from cell biology to animal physiology, Pharmacol. Rev. 54 (3), 431-467.
17. Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., Di Vizio, D., Hou, H., Jr., Kneitz, B., Lagaud, G., Christ, G. J., Edelmann, W., and Lisanti, M. P. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities, J. Biol. Chem. 276 (41), 38121-38138.
18. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., Schedl, A., Haller, H., and Kurzchalia, T. V. (2001) Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice, Science 293 (5539), 2449-2452.
19. Galbiati, F., Engelman, J. A., Volonte, D., Zhang, X. L., Minetti, C., Li, M., Hou, H., Kneitz, B., Edelmann, W., and Lisanti, M. P. (2001) Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities, J. Biol. Chem. 19, 19.
20. Razani, B., Wang, X. B., Engelman, J. A., Battista, M., Lagaud, G., Zhang, X. L., Kneitz, B., Hou, H., Jr., Christ, G. J., Edelmann, W., and Lisanti, M. P. (2002) Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae, Mol. Cell. Biol. 22 (7), 2329-2344.
21. Sowa, G., Pypaert, M., Fulton, D., and Sessa, W. C. (2003) The phosphorylation of caveolin-2 on serine 23 and 36 modulates caveolin-1-dependent caveolae formation, Proc. Natl. Acad. Sci. U.S.A. 100 (11), 6511-6516.
22. Sargiacomo, M., Scherer, P. E., Tang, Z.-L., Kubler, E., Song, K. S., Sanders, M. C., and Lisanti, M. P. (1995) Oligomeric structure of caveolin: Implications for caveolae membrane organization, Proc. Natl. Acad. Sci. U.S.A. 92, 9407-9411.
23. Murata, M., Peranen, J., Schreiner, R., Weiland, F., Kurzchalia, T., and Simons, K. (1995) VIP21/caveolin is a cholesterol-binding protein, Proc. Natl. Acad. Sci. U.S.A. 92, 10339-10343.
24. Monier, S., Parton, R. G., Vogel, F., Behlke, J., Henske, A., and Kurzchalia, T. (1995) VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro, Mol. Biol. Cell 6, 911-927.
25. Scherer, P. E., Lewis, R. Y., Volonte, D., Engelman, J. A., Galbiati, F., Couet, J., Kohtz, D. S., van Donselaar, E., Peters, P., and Lisanti, M. P. (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo, J. Biol. Chem. 272, 29337-29346.
26. Lisanti, M. P., Tang, Z.-L., and Sargiacomo, M. (1993) Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae, J. Cell Biol. 123, 595-604.
27. Galbiati, F., Razani, B., and Lisanti, M. P. (2001) Emerging themes in lipid rafts and caveolae, Cell 106 (4), 403-411.
28. Schlegel, A., and Lisanti, M. P. (2000) A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo, J. Biol. Chem. 275 (28), 21605-21617.
29. Song, K. S., Tang, Z.-L., Li, S., and Lisanti, M. P. (1997) Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homotypic caveolin-caveolin interactions, J. Biol. Chem. 272, 4398-4403.
30. Parolini, I., Sargiacomo, M., Galbiati, F., Rizzo, G., Grignani, F., Engelman, J. A., Okamoto, T., Ikezu, T., Scherer, P. E., Mora, R., Rodriguez-Boulan, E., Peschle, C., and Lisanti, M. P. (1999) Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex, J. Biol. Chem. 274 (36), 25718-25725.
31. Mora, R., Bonilha, V. L., Marmorstein, A., Scherer, P. E., Brown, D., Lisanti, M. P., and Rodriguez-Boulan, E. (1999) Caveolin-2 localizes to the Golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1, J. Biol. Chem. 274 (36), 25708-25717.
32. Lisanti, M. P., Scherer, P. E., Vidugiriene, J., Tang, Z.-L., Hermanoski-Vosatka, A., Tu, Y.-H., Cook, R. F., and Sargiacomo, M. (1994) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease, J. Cell Biol. 126, 111-126.
33. Li, S., Couet, J., and Lisanti, M. P. (1996) Src tyrosine kinases, Gα subunits and H-Ras share a common membrane-anchored scaffolding protein, Caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases, J. Biol. Chem. 271, 29182-29190.
34. Song, K. S., Li, S., Okamoto, T., Quilliam, L., Sargiacomo, M., and Lisanti, M. P. (1996) Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes, J. Biol. Chem. 271, 9690-9697.
35. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I., and Lisanti, M. P. (1995) Evidence for a regulated interaction of hetero-trimeric G proteins with caveolin. J. Biol. Chem. 270, 15693-15701.
36. Feron, O., Belhhassen, L., Kobzik, L., Smith, T. W., Kelly, R. A., and Michel, T. (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells, J. Biol. Chem. 271, 22810-22814.
37. Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J. E., and Sessa, W. C. (1996) Targeting of nitric oxide synthase to endothelilal cell caveolae via palmitoylation: implications for caveolae localization, Proc. Natl. Acad. Sci. U.S.A. 93, 6448-6453.
38. Song, K. S., Sargiacomo, M., Galbiati, F., Parenti, M., and Lisanti, M. P. (1997) Targeting of a Gα subunit (Gi1α) and c-Src tyrosine kinase to caveolae membranes: Clarifying the role of N-myristoylation, Cell. Mol. Biol. (Noisy-Le-Grand) 43, 293-303.
39. Glenney, J. R., Jr. (1989) Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus, J. Biol. Chem. 264 (34), 20163-20166.
40. Lee, H., Volonte, D., Galbiati, F., Iyengar, P., Lublin, D. M., Bregman, D. B., Wilson, M. T., Campos-Gonzalez, R., Bouzahzah, B., Pestell, R. G., Scherer, P. E., and Lisanti, M. P. (2000) Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette, Mol. Endocrinol. 14(11), 1750-1775.
41. Lee, H., Park, D. S., Wang, X. B., Scherer, P. E., Schwartz, P. E., and Lisanti, M. P. (2002) Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1, J. Biol. Chem. 277 (37), 34556-34567.
42. Koleske, A. J., Baltimore, D., and Lisanti, M. P. (1995) Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. U.S.A. 92 (5), 1381-1385.
43. Sargiacomo, M., Sudol, M., Tang, Z.-L., and Lisanti, M. P. (1993) Signal transducing molecules and GPI-linked proteins form a caveolin-rich insoluble complex in MDCK cells, J. Cell Biol. 122, 789-807.
44. Sargiacomo, M., Scherer, P. E., Tang, Z.-L., Casanova, J. E., and Lisanti, M. P. (1994) In vitro phosphorylation of caveolin-rich membrane domains: Identification of an associated serine kinase activity as a casein kinase II-like enzyme, Oncogene 9, 2589-2595.
45. Smart, E., Ying, Y.-S., Conrad, P., and Anderson, R. G. W. (1994) Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation, J. Cell Biol. 127, 1185-1197.
46. Corley-Mastick, C., Brady, M. J., and Saltiel, A. R. (1995) Insulin stimulates the tyrosine phosphorylation of caveolin, J. Cell Biol. 129, 1523-1531.
47. Scherer, P. E., Tang, Z.-L., Chun, M. C., Sargiacomo, M., Lodish, H. F., and Lisanti, M. P. (1995) Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: Identification and epitope mapping of an isoform-specific monoclonal antibody probe, J. Biol. Chem. 270, 16395-16401.
48. Sotgia, F., Lee, H., Bedford, M., Petrucci, T., Sudol, M., and Lisanti, M. P. (2001) Tyrosine phosphorylation of β-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins, Biochemistry 40 (48), 14585-14592.
49. Simons, K., and Ikonen, E. (1997) Functional rafts in cell membranes, Nature 387, 569-572.
50. Wary, K. K., Mariott, I. A., Zurzolo, C., and Giancotti, F. G. (1998) A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth, Cell 94, 625-634.